Pfizer explores sale of Hospira's infusion pump business for $2 bn
14 Jan 2016
US drug giant Pfizer Inc is mulling to sell hospital products maker Hospira's infusion pump business for about $2 billion, Bloomberg yesterday reported, citing people familiar with the matter.
Hospira, based in Illinois, was acquired last year by Pfizer for $17 billion.
The process is at a very early stage and the details could change, the report said. Pfizer may also choose not to sell the Hospira unit at this time, it added.
Infusion pumps are computerised medical devices that deliver fluids, such as nutrients and medications, into a patient's body in controlled amounts.
The proposed sale also comes two months after Pfizer agreed to buy Allergan Plc for $160 billion, a deal, if approved by regulators, would be the largest ever in the pharmaceutical industry.
.jpg "RBI keeps repo rate unchanged as focus remains on inflation")
.jpg "Indian Oil, Panasonic team up for lithium-ion cell production in India")
